Election 2008 - campaign contributions, lobbying, and the U.S. Health Sector.
作者信息
Steinbrook Robert
出版信息
N Engl J Med. 2007 Aug 23;357(8):736-9. doi: 10.1056/NEJMp078151.
PMID:17715407
Abstract
摘要
相似文献
1
Election 2008 - campaign contributions, lobbying, and the U.S. Health Sector.
N Engl J Med. 2007 Aug 23;357(8):736-9. doi: 10.1056/NEJMp078151.
2
Lobbying, campaign contributions, and health care reform.
N Engl J Med. 2009 Dec 3;361(23):e52. doi: 10.1056/NEJMp0910879. Epub 2009 Nov 18.
3
Campaign contributions, lobbying, and the U.S. health sector--an update.
N Engl J Med. 2008 Sep 25;359(13):1313-5. doi: 10.1056/NEJMp0807073.
4
Health care lobbying: time to make patients the special interest.
Am J Med. 2004 Apr 1;116(7):496-7. doi: 10.1016/j.amjmed.2004.02.011.
5
Reform bids draw dollars. In shift from 2000 and 2004, Democrats lead race to raise campaign funds from influence-seeking healthcare executives.
Mod Healthc. 2007 Nov 26;37(47):6-8, 10.
6
Health care reform's price fight.
Natl J (Wash). 1994 Aug 13;26(33):1923-4.
7
Interest group politics determines power players in reform debate.
Health Prog. 1994 Jun;75(5):14-6, 26.
8
America's other drug problem: how the drug industry distorts medicine and politics.
New Repub. 2002 Dec 16;227(25):27-41.
9
Health care reform hits the road.
Natl J (Wash). 1998 Jul 25;30(30):1761.
10
There they go again. This year's battle over health care reform is a political barometer.
US News World Rep. 1996 Apr 8;120(14):22-5.
引用本文的文献
1
The effects of lobbying on the FDA's recall classification.
BMC Med Ethics. 2023 Jun 20;24(1):41. doi: 10.1186/s12910-023-00921-0.
2
Lobbying Expenditures and Campaign Contributions by the Pharmaceutical and Health Product Industry in the United States, 1999-2018.
JAMA Intern Med. 2020 May 1;180(5):688-697. doi: 10.1001/jamainternmed.2020.0146.
Zotero 插件